Oscar Health (OSCR) Income towards Parent Company (2020 - 2026)

Oscar Health has reported Income towards Parent Company for 7 years, with the latest figure at $679.0 million in Q1 2026.

• For the quarter ending Q1 2026, Income towards Parent Company rose 146.46% year-over-year to $679.0 million; the trailing twelve-month figure through Mar 2026 stood at -$39.4 million (down 131.73% YoY), and the FY2025 full-year result was -$442.9 million, down 1795.58% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $679.0 million, up from -$352.4 million in the prior quarter.
• The five-year high for Income towards Parent Company was $679.0 million in Q1 2026, with the low at -$352.4 million in Q4 2025.
• Historically, Income towards Parent Company has averaged -$36.3 million across 5 years, with a median of -$77.3 million in 2022.
• Annual changes were most pronounced in 2024 — Income towards Parent Company soared 547.87% — and 2025, when it slumped 505.76%.
• Oscar Health's Income towards Parent Company stood at -$226.6 million in 2022, then jumped by 33.86% to -$149.8 million in 2023, then fell by 2.3% to -$153.3 million in 2024, then plunged by 129.92% to -$352.4 million in 2025, then soared by 292.67% to $679.0 million in 2026.
• The last three Income towards Parent Company figures came in at $679.0 million (Q1 2026), -$352.4 million (Q4 2025), and -$137.5 million (Q3 2025), per Business Quant data.